Neil Butler

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy.

Exploramed NC7, Inc. manufactures wearable breast pumps. It also offers milk bags and accessories, such as flange, flextube, and charger. The company was founded by Josh Makower in 2014 and is headquartered in Mountain View, CA.

Molecular Sensing Plc develops software and tools for DNA and RNA analysis. The company is headquartered in Melksham, the United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Eukarion, Inc. engages in the provision of medical research. It develops small molecule drugs for the treatment of degenerative and age-related disorders. The company was founded on January 25, 1991 and is headquartered in Arlington, MA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Sekisui Diagnostics LLC provides drug development, genetic testing and other services. Its product lines include clinical chemistry systems and reagents, coagulation systems and reagents, point of care rapid tests and immunoassay system, enzymes and specialty biochemicals. The company was founded in 1981 and is headquartered in Lexington, MA.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.

Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.

Advention Business Partners SAS provides investment consulting services. It offers its expertise to the consumer goods and retails; financial services; healthcare; manufacturing; private equity; social and public sector; utilities; tecnology; media; and telecommunications industries. The company was founded by Jean-Michel Schmitt and Anthony W. Besso in 2001 and is headquartered in Paris, France.

NHS England provides primary and mental health care services and is ultimately controlled by the Government of United Kingdom. The company is based in Redditch, UK. The CEO of the British company is Amanda Pritchard.

Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.

Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA.

Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France.

3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg.

Greenbone Ortho SRL develops a wood-derived bone implants technology to generate biomimetic implant suitable to address non-union fractures. It offers GreenBone that reproduce chemical composition and thee-dimensional architecture of natural tissues. The company was founded by Lorenzo Pradella in 2014 and is headquartered in Faenza, Italy.

Brilliant Home Technology, Inc. manufactures electronic products. Its products include single switch, two switches, three switches and four switches. The company was founded by Aaron Emigh, Steven Stanek, and Jeremy Hiatt in 2014 and is headquartered in San Mateo, CA.

PathAI, Inc. provides artificial intelligence powered technology for the pathology laboratory. It offers research and drug development, clinical and global health solutions. The firm specializes in pathology, digital pathology, oncology, immune-oncology, auto immune disease, neurodegenerative disease, companion diagnostics, precision medicine, solutions, research and development and computational pathology. The company was founded by Andrew H. Beck and Aditya Khosla in 2016 and is headquartered in Cambridge, MA.

Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber.

GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.

Mirvie, Inc. provides precise, actionable, non-invasive tests for maternal-fetal health. The company is headquartered in South San Francisco, CA.

Part of NHS Ayrshire & Arran, East Ayrshire Community Hospital operates as a hospital. The company is based in Cumnock, UK. The CEO of the British company is John Burns. East Ayrshire Community Hospital was acquired by NHS Ayrshire & Arran on May 27, 2021 for $16.95 million.

Readygo Diagnostics Ltd. provides professional, scientific, and technical services. The company is based in Chippenham, UK.

Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021.

Whitelab Genomics SAS is a French company that develops software solutions using AI to accelerate and de-risk gene and cell therapy developments. The company is based in Evry, France. The company's analytical solutions provide a wide range of answers to scientific and technological questions. The company is developing a unique AI platform dedicated to accelerated gene and cell therapy development. The company was founded in 2019 by David Del Bourgo, Julien Cottineau. David Del Bourgo has been the CEO since 2019.